Drugmakers, insurers, hospitals, pharmacies, medical devices, clinical updates, and healthcare business leaders.
A public market fight over obesity treatments is expanding beyond injections, as Eli Lilly and Novo Nordisk compete to capture demand for oral weight-loss drugs and defend their broader positions in the obesity market.
THE APEX TIMES
THE APEX TIMES
The market reacted sharply to late-stage trial results for a cancer vaccine targeting melanoma patients, sending Moderna shares up more than 60% and lifting Merck’s stock as well.
THE APEX TIMES
A Yahoo Finance market wrap on Aug. 19 highlighted Moderna and other widely held stocks as traders focused on the Fed for clues about the path of interest rates.
THE APEX TIMES
The jump follows Moderna’s announcement of successful results for an experimental melanoma vaccine, driving a sharp move in its stock ahead of the regular session.
THE APEX TIMES
The companies said their Phase 3 trial combining Moderna’s intismeran autogene with Merck’s KEYTRUDA met key recurrence and distant metastasis endpoints in patients whose tumors were completely removed.
THE APEX TIMES
The agency is challenging how UnitedHealth moved money across borders, arguing the company’s U.S. taxable income should be higher for four consecutive tax years. UnitedHealth did not say what the dispute involves in dollars, and both sides declined to estimate potential impact.
THE APEX TIMES
A Yahoo Finance market update says CVS Health is back in focus as investors weigh a potentially stronger outlook against recent board reshuffling and new management outlines.
THE APEX TIMES
CVS Health said it has reshuffled its board, with Larry M. Robbins stepping down and Teresa Heitsenrether, a senior JPMorgan Chase executive, taking his place.
THE APEX TIMES
A new comparison of UnitedHealth Group and Eli Lilly highlights that both companies maintain dividend programs with long-running appeal, while their dividend maturity levels appear to differ.
